The Nanotechnology in the Medical Devices Market in the Middle East & Africa was worth USD 774.28 Million in 2021 and is expected to reach USD 1503.93 Million by 2026, hiking at a CAGR of 14.2% between 2021 to 2026.
Nanotechnology has enormous potential to transform the healthcare sector, and it has grown rapidly across the Middle East and Africa over the last decade. Because of technological improvements and the rising prevalence of diseases associated with an older population, the market is likely to continue to grow in the future. There is growing anticipation that nanotechnology in medicine will lead to considerable improvements in illness diagnosis, treatment, and prevention.
Nanotechnology in medical devices has seen tremendous expansion, owing to increased government investment in nanotechnology research and development and greater international collaboration in research and the aging population in the Middle East and Africa. In addition, individuals' more excellent knowledge, rising healthcare expenditures, and the availability of reimbursement and insurance coverage for healthcare expenditures drive the market.
Nanotechnology in medical devices uses nano-robots to perform repairs at the cellular level, with dimensions that are frequently fractions of the width of a human hair and is expected to transform how we cure and detect human body damage. Many Nanotechnology applications are also in various testing phases and provide intriguing opportunities in the future. In the future years, nanotechnology across medicine can save a large number of lives in the Middle East and Africa.
High prices associated with nanotechnology-based medical equipment and stringent regulations that make product clearance time-consuming are limiting the market for nanotechnology in medical devices in this region. The virus began to spread worldwide in the first few months of 2020, affecting millions of people. As the COVID 19 eruption occurred, the global economy experienced a 4% drop. Work orders have been stopped in most countries, along with food restrictions. The medical device industry in the Middle East and Africa has been significantly impacted by nanotechnology. Except for medical equipment suppliers and life-saving products, all other sectors have suffered significant damage.
This research report on the MEA nanotechnology in the medical devices market has been segmented and sub-segmented into the following categories:
The Middle East and Africa market for nanotechnology-based medicinal solutions is growing rapidly. Factors such as the aging population, rising R&D spending, greater international research collaboration, and the expanding healthcare industry propel the market forward. Saudi Arabia, the United Arab Emirates, and Israel are key contributors to the global market.
The majority of the stock's value is accounted for by the highly developed healthcare system, various manufacturing businesses, and government-sponsored development programs.
Nanotechnology is offering new opportunities to prevent, diagnose, and treat COVID-19 and other viral diseases. In the Middle East and Africa, these factors are projected to drive the market for nanotechnology in medical devices over the coming years.
During the forecast period, Saudi Arabia is expected to dominate the Middle East and Africa Nanotechnology in the Medical Devices market. This is attributed to an increase in the prevalence of cancer, genetic, and cardiovascular disorders, advances in nanoscale diagnostic technologies, and a growing appetite for tailored medications.
In the Middle East and Africa Nanotechnology in Medical Devices market, the UAE has the second-largest share. The increased prevalence of dementia is likely to raise demand for effective nanomedicine-based treatments in managing the illness, propelling the market growth.
KEY MARKET PLAYERS:
Companies playing a dominant in the MEA Nanotechnology in Medical Devices Market covered in this report are AMAG pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., Perkin Elmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies, and Stryker Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
126.96.36.199 Bone Restorative Material
188.8.131.52 Dental Filling Material
5.1.2active implantable material
184.108.40.206 Hearing Aid Devices
220.127.116.11 Cardio Rhythm Management Devices
5.1.4 Medical Textile and Wound Dressing
5.2 By Application
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
a) List of Tables
b) List of Figures